GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gtf2i
|
ENSRNOG00000001479 | general transcription factor II I |
Gtf2f1
|
ENSRNOG00000047134 | general transcription factor IIF subunit 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Gtf2f1 | rn6_v1_chr9_+_10033011_10033011 | 0.71 | 9.2e-50 | Click! |
Gtf2i | rn6_v1_chr12_+_25435567_25435567 | 0.70 | 1.6e-47 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_56627411 | 52.44 |
ENSRNOT00000089108
ENSRNOT00000068493 |
Dlg4
|
discs large MAGUK scaffold protein 4 |
chrX_-_124464963 | 52.18 |
ENSRNOT00000036472
ENSRNOT00000077697 |
Tmem255a
|
transmembrane protein 255A |
chrX_-_123662350 | 38.86 |
ENSRNOT00000092624
|
Sept6
|
septin 6 |
chr17_-_10766253 | 38.13 |
ENSRNOT00000000117
|
Cplx2
|
complexin 2 |
chr20_+_5535432 | 37.06 |
ENSRNOT00000040859
|
Syngap1
|
synaptic Ras GTPase activating protein 1 |
chr5_-_75319765 | 35.99 |
ENSRNOT00000085698
|
Svep1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
chr19_+_2393059 | 35.81 |
ENSRNOT00000018535
|
Cdh11
|
cadherin 11 |
chr14_+_70780623 | 33.48 |
ENSRNOT00000083871
ENSRNOT00000058803 |
Ldb2
|
LIM domain binding 2 |
chr11_-_11585765 | 30.26 |
ENSRNOT00000066439
|
Robo2
|
roundabout guidance receptor 2 |
chr5_-_75319189 | 29.72 |
ENSRNOT00000047200
|
Svep1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
chr20_-_1984737 | 28.62 |
ENSRNOT00000040232
ENSRNOT00000051634 ENSRNOT00000079445 |
Gabbr1
|
gamma-aminobutyric acid type B receptor subunit 1 |
chr8_+_49418965 | 27.29 |
ENSRNOT00000021819
|
Scn2b
|
sodium voltage-gated channel beta subunit 2 |
chr4_-_157381105 | 26.90 |
ENSRNOT00000021670
|
Gpr162
|
G protein-coupled receptor 162 |
chr10_+_93520132 | 25.63 |
ENSRNOT00000055137
|
Mrc2
|
mannose receptor, C type 2 |
chr3_-_107760550 | 25.30 |
ENSRNOT00000077091
ENSRNOT00000051638 |
Meis2
|
Meis homeobox 2 |
chr1_-_72727112 | 25.19 |
ENSRNOT00000031172
|
Brsk1
|
BR serine/threonine kinase 1 |
chr20_+_10123651 | 24.89 |
ENSRNOT00000001559
|
Pde9a
|
phosphodiesterase 9A |
chr1_-_81946714 | 24.05 |
ENSRNOT00000027578
|
Grik5
|
glutamate ionotropic receptor kainate type subunit 5 |
chr18_-_6474990 | 23.06 |
ENSRNOT00000061504
|
Kctd1
|
potassium channel tetramerization domain containing 1 |
chr3_-_176816114 | 22.96 |
ENSRNOT00000079262
ENSRNOT00000018697 |
Stmn3
|
stathmin 3 |
chr10_+_82800704 | 22.81 |
ENSRNOT00000089497
|
Ppp1r9b
|
protein phosphatase 1, regulatory subunit 9B |
chr13_+_71192142 | 22.66 |
ENSRNOT00000032157
|
Rnasel
|
ribonuclease L |
chr1_+_101682172 | 22.09 |
ENSRNOT00000028540
|
Car11
|
carbonic anhydrase 11 |
chr11_+_58624198 | 21.77 |
ENSRNOT00000002091
|
Gap43
|
growth associated protein 43 |
chr8_-_13262729 | 21.76 |
ENSRNOT00000012176
|
Fut4
|
fucosyltransferase 4 |
chr1_-_82279145 | 21.76 |
ENSRNOT00000057433
|
Cxcl17
|
C-X-C motif chemokine ligand 17 |
chr10_+_23661013 | 21.76 |
ENSRNOT00000076664
|
Ebf1
|
early B-cell factor 1 |
chr17_+_83221827 | 21.60 |
ENSRNOT00000000155
|
Plxdc2
|
plexin domain containing 2 |
chr12_+_27155587 | 21.46 |
ENSRNOT00000044800
|
AABR07035916.1
|
|
chr14_-_6679878 | 21.35 |
ENSRNOT00000075989
ENSRNOT00000067875 |
Spp1
|
secreted phosphoprotein 1 |
chrX_+_107496072 | 20.63 |
ENSRNOT00000003283
|
Plp1
|
proteolipid protein 1 |
chr3_+_123731539 | 20.24 |
ENSRNOT00000051064
|
Cdc25b
|
cell division cycle 25B |
chr3_-_29996865 | 20.14 |
ENSRNOT00000080382
|
Zeb2
|
zinc finger E-box binding homeobox 2 |
chr2_+_54191538 | 19.87 |
ENSRNOT00000019524
|
Plcxd3
|
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
chr10_-_82887497 | 19.86 |
ENSRNOT00000005644
|
Itga3
|
integrin subunit alpha 3 |
chrX_-_134719097 | 19.78 |
ENSRNOT00000068478
|
Smarca1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
chr4_-_159697207 | 19.65 |
ENSRNOT00000086440
|
Ccnd2
|
cyclin D2 |
chr20_-_1980101 | 19.63 |
ENSRNOT00000084582
ENSRNOT00000085050 ENSRNOT00000082545 ENSRNOT00000088396 |
Gabbr1
|
gamma-aminobutyric acid type B receptor subunit 1 |
chr2_-_186515135 | 19.49 |
ENSRNOT00000077375
|
Kirrel
|
kin of IRRE like (Drosophila) |
chr7_-_119768082 | 19.44 |
ENSRNOT00000009612
|
Sstr3
|
somatostatin receptor 3 |
chr8_+_44847157 | 19.36 |
ENSRNOT00000080288
|
Clmp
|
CXADR-like membrane protein |
chr1_+_199664173 | 19.20 |
ENSRNOT00000054980
|
Tgfb1i1
|
transforming growth factor beta 1 induced transcript 1 |
chr2_+_205160405 | 18.60 |
ENSRNOT00000035605
|
Tspan2
|
tetraspanin 2 |
chr16_-_20097287 | 18.06 |
ENSRNOT00000025162
|
Unc13a
|
unc-13 homolog A |
chr3_+_129753742 | 17.91 |
ENSRNOT00000007998
ENSRNOT00000080581 |
Snap25
|
synaptosomal-associated protein 25 |
chr10_+_23661343 | 17.64 |
ENSRNOT00000047970
|
Ebf1
|
early B-cell factor 1 |
chr16_+_35934970 | 17.41 |
ENSRNOT00000084707
ENSRNOT00000016474 |
Galnt7
|
polypeptide N-acetylgalactosaminyltransferase 7 |
chr7_+_140315368 | 17.40 |
ENSRNOT00000081206
|
Cacnb3
|
calcium voltage-gated channel auxiliary subunit beta 3 |
chr15_+_15275541 | 17.31 |
ENSRNOT00000012153
|
Cadps
|
calcium dependent secretion activator |
chr1_-_20962526 | 16.56 |
ENSRNOT00000061332
ENSRNOT00000017322 ENSRNOT00000017412 ENSRNOT00000079688 ENSRNOT00000017417 |
Epb41l2
|
erythrocyte membrane protein band 4.1-like 2 |
chr1_+_234252757 | 16.49 |
ENSRNOT00000091814
|
Rorb
|
RAR-related orphan receptor B |
chr13_+_90723092 | 16.19 |
ENSRNOT00000010146
|
Kcnj10
|
ATP-sensitive inward rectifier potassium channel 10 |
chrX_+_158835811 | 16.15 |
ENSRNOT00000071888
ENSRNOT00000080110 |
Ints6l
|
integrator complex subunit 6 like |
chrX_-_15707436 | 15.85 |
ENSRNOT00000085907
|
Syp
|
synaptophysin |
chr8_+_7128656 | 15.45 |
ENSRNOT00000038313
|
Pgr
|
progesterone receptor |
chr4_+_117371659 | 15.38 |
ENSRNOT00000045735
|
Alms1
|
ALMS1, centrosome and basal body associated protein |
chr18_+_63599425 | 15.38 |
ENSRNOT00000023145
|
Cep192
|
centrosomal protein 192 |
chr3_-_143063983 | 15.02 |
ENSRNOT00000006329
|
Napb
|
NSF attachment protein beta |
chr5_+_159512285 | 14.99 |
ENSRNOT00000010884
ENSRNOT00000088082 |
Atp13a2
|
ATPase 13A2 |
chrX_+_20316893 | 14.91 |
ENSRNOT00000082177
|
Wnk3
|
WNK lysine deficient protein kinase 3 |
chr12_-_38782010 | 14.83 |
ENSRNOT00000001813
|
Wdr66
|
WD repeat domain 66 |
chr13_-_90589466 | 14.81 |
ENSRNOT00000070812
|
Pea15
|
phosphoprotein enriched in astrocytes 15 |
chrX_-_123601100 | 14.74 |
ENSRNOT00000092546
ENSRNOT00000092301 |
Sept6
|
septin 6 |
chr6_-_46631983 | 14.56 |
ENSRNOT00000045963
|
Sox11
|
SRY box 11 |
chr17_+_43050789 | 14.49 |
ENSRNOT00000080745
|
Carmil1
|
capping protein regulator and myosin 1 linker 1 |
chr5_+_137257637 | 14.47 |
ENSRNOT00000093001
|
Elovl1
|
ELOVL fatty acid elongase 1 |
chr20_+_3556560 | 14.46 |
ENSRNOT00000085635
|
Ddr1
|
discoidin domain receptor tyrosine kinase 1 |
chr10_-_55965216 | 14.45 |
ENSRNOT00000057058
|
Chd3
|
chromodomain helicase DNA binding protein 3 |
chrX_+_105239620 | 14.36 |
ENSRNOT00000085693
|
Drp2
|
dystrophin related protein 2 |
chrX_+_105239840 | 14.33 |
ENSRNOT00000039864
|
Drp2
|
dystrophin related protein 2 |
chr3_+_113318563 | 14.28 |
ENSRNOT00000089230
|
Ckmt1
|
creatine kinase, mitochondrial 1 |
chr1_-_199270627 | 14.24 |
ENSRNOT00000026063
|
Stx1b
|
syntaxin 1B |
chr12_-_2592838 | 14.18 |
ENSRNOT00000079918
|
Evi5l
|
ecotropic viral integration site 5-like |
chr1_-_85300825 | 14.05 |
ENSRNOT00000057073
ENSRNOT00000026900 |
Lrfn1
|
leucine rich repeat and fibronectin type III domain containing 1 |
chr8_+_67733215 | 14.03 |
ENSRNOT00000034926
|
Cln6
|
ceroid-lipofuscinosis, neuronal 6, late infantile, variant |
chr2_-_179704629 | 14.01 |
ENSRNOT00000083361
ENSRNOT00000077941 |
Gria2
|
glutamate ionotropic receptor AMPA type subunit 2 |
chrX_-_115908693 | 13.71 |
ENSRNOT00000091423
|
Trpc5
|
transient receptor potential cation channel, subfamily C, member 5 |
chr7_-_50638798 | 13.71 |
ENSRNOT00000048880
|
Syt1
|
synaptotagmin 1 |
chr1_-_43638161 | 13.68 |
ENSRNOT00000024460
|
Ipcef1
|
interaction protein for cytohesin exchange factors 1 |
chr3_+_2462466 | 13.65 |
ENSRNOT00000014087
|
Rnf208
|
ring finger protein 208 |
chrX_+_15273933 | 13.62 |
ENSRNOT00000075082
|
LOC108348091
|
erythroid transcription factor |
chr4_-_64831233 | 13.59 |
ENSRNOT00000079285
|
Dgki
|
diacylglycerol kinase, iota |
chr1_+_78069193 | 13.59 |
ENSRNOT00000068406
|
Meis3
|
Meis homeobox 3 |
chr16_-_48437223 | 13.54 |
ENSRNOT00000013005
ENSRNOT00000059401 |
Enpp6
|
ectonucleotide pyrophosphatase/phosphodiesterase 6 |
chr12_+_12756452 | 13.44 |
ENSRNOT00000001382
ENSRNOT00000092462 |
Ankrd61
|
ankyrin repeat domain 61 |
chr17_+_43050961 | 13.23 |
ENSRNOT00000059510
|
Carmil1
|
capping protein regulator and myosin 1 linker 1 |
chr7_-_36000906 | 13.15 |
ENSRNOT00000011178
|
Plxnc1
|
plexin C1 |
chr17_-_48562838 | 13.12 |
ENSRNOT00000017102
ENSRNOT00000084702 |
Amph
|
amphiphysin |
chr14_+_108826831 | 13.09 |
ENSRNOT00000083146
ENSRNOT00000009421 |
Bcl11a
|
B-cell CLL/lymphoma 11A |
chr3_+_113319456 | 13.05 |
ENSRNOT00000051354
|
Ckmt1
|
creatine kinase, mitochondrial 1 |
chr3_-_29993715 | 13.03 |
ENSRNOT00000085801
|
Zeb2
|
zinc finger E-box binding homeobox 2 |
chr10_+_89089646 | 13.01 |
ENSRNOT00000027505
|
Cntnap1
|
contactin associated protein 1 |
chr4_+_145413230 | 12.95 |
ENSRNOT00000056508
|
Il17re
|
interleukin 17 receptor E |
chr14_+_75852060 | 12.90 |
ENSRNOT00000075975
|
Hs3st1
|
heparan sulfate-glucosamine 3-sulfotransferase 1 |
chrX_-_123600890 | 12.89 |
ENSRNOT00000067942
|
Sept6
|
septin 6 |
chr15_-_82482009 | 12.87 |
ENSRNOT00000011926
|
Dach1
|
dachshund family transcription factor 1 |
chr4_+_42692836 | 12.82 |
ENSRNOT00000085043
|
Cftr
|
cystic fibrosis transmembrane conductance regulator |
chr16_-_5795825 | 12.81 |
ENSRNOT00000048043
|
Cacna2d3
|
calcium voltage-gated channel auxiliary subunit alpha2delta 3 |
chr4_+_57050214 | 12.77 |
ENSRNOT00000025165
|
Ahcyl2
|
adenosylhomocysteinase-like 2 |
chr18_+_57286322 | 12.74 |
ENSRNOT00000026174
|
Sh3tc2
|
SH3 domain and tetratricopeptide repeats 2 |
chr11_+_66932614 | 12.56 |
ENSRNOT00000003189
|
Slc15a2
|
solute carrier family 15 member 2 |
chr13_-_81214494 | 12.51 |
ENSRNOT00000004950
ENSRNOT00000082385 |
Prrx1
|
paired related homeobox 1 |
chr20_+_3556975 | 12.48 |
ENSRNOT00000089417
|
Ddr1
|
discoidin domain receptor tyrosine kinase 1 |
chr12_-_46920952 | 12.40 |
ENSRNOT00000001532
|
Msi1
|
musashi RNA-binding protein 1 |
chr5_+_137257287 | 12.40 |
ENSRNOT00000037160
|
Elovl1
|
ELOVL fatty acid elongase 1 |
chr10_+_84147836 | 12.27 |
ENSRNOT00000010527
|
Hoxb6
|
homeo box B6 |
chr7_-_2588843 | 12.25 |
ENSRNOT00000088619
|
Rbms2
|
RNA binding motif, single stranded interacting protein 2 |
chr4_-_64330996 | 12.25 |
ENSRNOT00000016088
|
Ptn
|
pleiotrophin |
chrX_-_105622156 | 12.21 |
ENSRNOT00000029511
|
Armcx2
|
armadillo repeat containing, X-linked 2 |
chrX_+_70563570 | 12.17 |
ENSRNOT00000003772
|
Gdpd2
|
glycerophosphodiester phosphodiesterase domain containing 2 |
chr19_-_52499433 | 12.16 |
ENSRNOT00000021954
|
Cotl1
|
coactosin-like F-actin binding protein 1 |
chr16_+_7303578 | 12.07 |
ENSRNOT00000025656
|
Sema3g
|
semaphorin 3G |
chr14_+_16341536 | 11.95 |
ENSRNOT00000002924
|
Ccni
|
cyclin I |
chr9_+_18564927 | 11.82 |
ENSRNOT00000061014
|
Runx2
|
runt-related transcription factor 2 |
chr1_+_78025995 | 11.73 |
ENSRNOT00000086396
|
Slc8a2
|
solute carrier family 8 member A2 |
chr1_-_140262452 | 11.73 |
ENSRNOT00000046849
ENSRNOT00000045165 ENSRNOT00000025536 ENSRNOT00000041839 |
Ntrk3
|
neurotrophic receptor tyrosine kinase 3 |
chr3_-_29984201 | 11.67 |
ENSRNOT00000006350
|
Zeb2
|
zinc finger E-box binding homeobox 2 |
chr20_+_5527181 | 11.48 |
ENSRNOT00000091364
|
Phf1
|
PHD finger protein 1 |
chr1_-_216918969 | 11.46 |
ENSRNOT00000079454
|
Osbpl5
|
oxysterol binding protein-like 5 |
chr1_-_98521706 | 11.45 |
ENSRNOT00000015941
|
Siglec10
|
sialic acid binding Ig-like lectin 10 |
chr4_+_157374318 | 11.40 |
ENSRNOT00000071027
|
AC115420.2
|
|
chr5_-_40237591 | 11.40 |
ENSRNOT00000011393
|
Fut9
|
fucosyltransferase 9 |
chr4_+_30807879 | 11.37 |
ENSRNOT00000013184
|
Dync1i1
|
dynein cytoplasmic 1 intermediate chain 1 |
chr19_-_58735173 | 11.34 |
ENSRNOT00000030077
|
Pcnx2
|
pecanex homolog 2 (Drosophila) |
chr2_-_219262901 | 11.32 |
ENSRNOT00000037068
|
Gpr88
|
G-protein coupled receptor 88 |
chr3_+_129599353 | 11.31 |
ENSRNOT00000008734
|
Snap25
|
synaptosomal-associated protein 25 |
chr1_+_162817611 | 11.22 |
ENSRNOT00000091952
|
Pak1
|
p21 (RAC1) activated kinase 1 |
chr17_+_9679628 | 11.21 |
ENSRNOT00000019569
ENSRNOT00000019393 |
Dbn1
|
drebrin 1 |
chr5_+_131257127 | 11.19 |
ENSRNOT00000010628
|
Bend5
|
BEN domain containing 5 |
chr7_+_3133506 | 11.07 |
ENSRNOT00000049972
|
Pmel
|
premelanosome protein |
chr10_-_18942540 | 11.02 |
ENSRNOT00000007187
|
Kcnip1
|
potassium voltage-gated channel interacting protein 1 |
chr2_+_230901126 | 11.01 |
ENSRNOT00000016026
ENSRNOT00000015564 ENSRNOT00000068198 |
Camk2d
|
calcium/calmodulin-dependent protein kinase II delta |
chr18_+_30172740 | 11.01 |
ENSRNOT00000027340
|
Pcdha4
|
protocadherin alpha 4 |
chr14_-_45797887 | 10.91 |
ENSRNOT00000029209
|
Tbc1d1
|
TBC1 domain family member 1 |
chr18_+_31094965 | 10.91 |
ENSRNOT00000026526
|
Rell2
|
RELT-like 2 |
chr2_+_220298245 | 10.89 |
ENSRNOT00000022625
|
Plppr4
|
phospholipid phosphatase related 4 |
chr1_-_101903910 | 10.81 |
ENSRNOT00000028656
|
Emp3
|
epithelial membrane protein 3 |
chr14_+_100217289 | 10.75 |
ENSRNOT00000077171
ENSRNOT00000007104 |
Cnrip1
|
cannabinoid receptor interacting protein 1 |
chr13_-_52413681 | 10.68 |
ENSRNOT00000037100
ENSRNOT00000011801 |
Nav1
|
neuron navigator 1 |
chr19_+_55929609 | 10.68 |
ENSRNOT00000068231
ENSRNOT00000077701 |
Cpne7
|
copine 7 |
chrX_-_104493714 | 10.64 |
ENSRNOT00000064458
ENSRNOT00000080386 |
Pcdh19
|
protocadherin 19 |
chr18_-_47513030 | 10.63 |
ENSRNOT00000083881
ENSRNOT00000074226 |
Lox
|
lysyl oxidase |
chr17_-_10952441 | 10.49 |
ENSRNOT00000024580
|
Hrh2
|
histamine receptor H 2 |
chr3_-_148057523 | 10.49 |
ENSRNOT00000055408
|
Defb24
|
defensin beta 24 |
chr3_-_147143576 | 10.49 |
ENSRNOT00000091811
ENSRNOT00000012727 |
Snph
|
syntaphilin |
chr9_+_38297322 | 10.48 |
ENSRNOT00000078157
ENSRNOT00000088824 |
Bend6
|
BEN domain containing 6 |
chr10_+_106065712 | 10.47 |
ENSRNOT00000003690
|
Sec14l1
|
SEC14-like lipid binding 1 |
chr3_+_122114754 | 10.47 |
ENSRNOT00000006408
|
Sirpa
|
signal-regulatory protein alpha |
chr7_-_70476340 | 10.44 |
ENSRNOT00000006800
|
Arhgef25
|
Rho guanine nucleotide exchange factor 25 |
chr2_+_174013288 | 10.44 |
ENSRNOT00000013904
|
Serpini1
|
serpin family I member 1 |
chr1_+_226435979 | 10.39 |
ENSRNOT00000048704
ENSRNOT00000036232 ENSRNOT00000035576 ENSRNOT00000036180 ENSRNOT00000036168 ENSRNOT00000047964 ENSRNOT00000036283 ENSRNOT00000007429 |
Syt7
|
synaptotagmin 7 |
chr10_-_64657089 | 10.38 |
ENSRNOT00000080703
|
Abr
|
active BCR-related |
chr17_-_88095729 | 10.37 |
ENSRNOT00000025140
|
Enkur
|
enkurin, TRPC channel interacting protein |
chr15_+_34520142 | 10.33 |
ENSRNOT00000074659
|
Nynrin
|
NYN domain and retroviral integrase containing |
chr2_+_266315036 | 10.28 |
ENSRNOT00000055245
|
Wls
|
wntless Wnt ligand secretion mediator |
chr14_+_19866408 | 10.28 |
ENSRNOT00000060465
|
Adamts3
|
ADAM metallopeptidase with thrombospondin type 1, motif 3 |
chr19_+_53723822 | 10.27 |
ENSRNOT00000023478
|
RGD1304884
|
similar to RIKEN cDNA 6430548M08 |
chr15_+_44799334 | 10.21 |
ENSRNOT00000018599
|
Nefl
|
neurofilament light |
chr1_+_199196059 | 10.20 |
ENSRNOT00000090428
|
Fbxl19
|
F-box and leucine-rich repeat protein 19 |
chr7_-_2588686 | 10.17 |
ENSRNOT00000048848
|
Rbms2
|
RNA binding motif, single stranded interacting protein 2 |
chr10_-_47725172 | 10.07 |
ENSRNOT00000003228
|
Rnf112
|
ring finger protein 112 |
chr1_+_80092403 | 10.06 |
ENSRNOT00000078336
|
Eml2
|
echinoderm microtubule associated protein like 2 |
chr13_+_82369493 | 10.06 |
ENSRNOT00000003733
|
Sell
|
selectin L |
chrX_-_112473822 | 10.00 |
ENSRNOT00000079180
|
Col4a6
|
collagen type IV alpha 6 chain |
chr15_-_20783063 | 9.97 |
ENSRNOT00000083268
|
Bmp4
|
bone morphogenetic protein 4 |
chr8_-_36314811 | 9.85 |
ENSRNOT00000013243
|
St3gal4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
chr18_-_24182012 | 9.83 |
ENSRNOT00000023594
|
Syt4
|
synaptotagmin 4 |
chr9_-_84894599 | 9.81 |
ENSRNOT00000018423
|
Hdac1l
|
histone deacetylase 1-like |
chr2_-_207300854 | 9.80 |
ENSRNOT00000018061
|
Mov10
|
Mov10 RISC complex RNA helicase |
chr9_-_92291220 | 9.79 |
ENSRNOT00000093357
|
Dner
|
delta/notch-like EGF repeat containing |
chr14_-_100217913 | 9.78 |
ENSRNOT00000079167
|
Plek
|
pleckstrin |
chr4_-_11497531 | 9.77 |
ENSRNOT00000078799
|
Magi2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
chr5_-_58950373 | 9.76 |
ENSRNOT00000060442
|
Cd72
|
Cd72 molecule |
chr8_-_6305033 | 9.73 |
ENSRNOT00000029887
|
Cep126
|
centrosomal protein 126 |
chr4_+_160168297 | 9.73 |
ENSRNOT00000083226
|
Cracr2a
|
calcium release activated channel regulator 2A |
chr9_+_9961021 | 9.68 |
ENSRNOT00000075767
|
Tubb4a
|
tubulin, beta 4A class IVa |
chr6_-_2311781 | 9.65 |
ENSRNOT00000084171
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1 |
chr2_-_123396147 | 9.62 |
ENSRNOT00000079004
|
Trpc3
|
transient receptor potential cation channel, subfamily C, member 3 |
chr2_-_123396386 | 9.59 |
ENSRNOT00000046700
|
Trpc3
|
transient receptor potential cation channel, subfamily C, member 3 |
chrX_+_67656253 | 9.58 |
ENSRNOT00000009129
|
Ar
|
androgen receptor |
chr3_+_81498022 | 9.58 |
ENSRNOT00000010510
|
Chst1
|
carbohydrate sulfotransferase 1 |
chr18_-_12640716 | 9.55 |
ENSRNOT00000020697
|
Klhl14
|
kelch-like family member 14 |
chr3_-_121882726 | 9.49 |
ENSRNOT00000006308
|
Il1b
|
interleukin 1 beta |
chr1_+_280633938 | 9.47 |
ENSRNOT00000012564
|
Emx2
|
empty spiracles homeobox 2 |
chr15_+_48674380 | 9.43 |
ENSRNOT00000018762
|
Fbxo16
|
F-box protein 16 |
chr1_-_197821936 | 9.42 |
ENSRNOT00000055027
|
Cd19
|
CD19 molecule |
chr18_-_37776453 | 9.41 |
ENSRNOT00000087876
|
Dpysl3
|
dihydropyrimidinase-like 3 |
chr12_+_41073824 | 9.40 |
ENSRNOT00000001844
|
Rph3a
|
rabphilin 3A |
chr1_-_8878136 | 9.36 |
ENSRNOT00000064836
ENSRNOT00000075850 |
Vta1
|
vesicle trafficking 1 |
chr15_-_33576331 | 9.31 |
ENSRNOT00000021851
|
Slc22a17
|
solute carrier family 22, member 17 |
chr7_+_2831004 | 9.27 |
ENSRNOT00000029778
|
Rnf41
|
ring finger protein 41 |
chr3_+_111049118 | 9.27 |
ENSRNOT00000088870
|
Spint1
|
serine peptidase inhibitor, Kunitz type 1 |
chr4_-_51844331 | 9.26 |
ENSRNOT00000003593
|
Gpr37
|
G protein-coupled receptor 37 |
chr2_-_30458542 | 9.25 |
ENSRNOT00000072926
|
Naip6
|
NLR family, apoptosis inhibitory protein 6 |
chr17_-_44640092 | 9.24 |
ENSRNOT00000077628
|
Zfp184
|
zinc finger protein 184 |
chr11_-_11585078 | 9.24 |
ENSRNOT00000088878
|
Robo2
|
roundabout guidance receptor 2 |
chr6_-_15191660 | 9.20 |
ENSRNOT00000092654
|
Nrxn1
|
neurexin 1 |
chr5_+_150754021 | 9.18 |
ENSRNOT00000017687
|
Ptafr
|
platelet-activating factor receptor |
chr10_-_47724499 | 9.11 |
ENSRNOT00000085011
|
Rnf112
|
ring finger protein 112 |
chr3_-_120233655 | 9.11 |
ENSRNOT00000020870
|
Mal
|
mal, T-cell differentiation protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.9 | 44.8 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
13.2 | 39.6 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
12.9 | 38.7 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
10.5 | 52.4 | GO:0098970 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
8.0 | 48.2 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
7.9 | 23.8 | GO:0006710 | androgen catabolic process(GO:0006710) |
7.9 | 39.5 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
7.3 | 29.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
7.2 | 21.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
6.9 | 27.7 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
6.9 | 34.5 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
6.3 | 44.3 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
6.3 | 25.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
6.2 | 24.8 | GO:0030221 | basophil differentiation(GO:0030221) |
5.7 | 17.0 | GO:1904373 | response to kainic acid(GO:1904373) |
5.6 | 16.7 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
5.4 | 16.2 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
5.1 | 10.3 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
5.1 | 20.5 | GO:0010157 | response to chlorate(GO:0010157) |
5.0 | 20.1 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
5.0 | 15.0 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) lysosomal protein catabolic process(GO:1905146) |
5.0 | 20.0 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
5.0 | 20.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
5.0 | 24.9 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
5.0 | 14.9 | GO:2000682 | positive regulation of rubidium ion transport(GO:2000682) positive regulation of rubidium ion transmembrane transporter activity(GO:2000688) |
5.0 | 14.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
4.9 | 48.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
4.6 | 18.6 | GO:0070560 | protein secretion by platelet(GO:0070560) |
4.6 | 13.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
4.4 | 30.6 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
4.3 | 12.8 | GO:0071454 | cellular response to anoxia(GO:0071454) |
4.2 | 20.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
4.1 | 12.4 | GO:0009609 | response to symbiotic bacterium(GO:0009609) |
4.0 | 8.0 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
3.9 | 7.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
3.9 | 27.3 | GO:0046684 | response to pyrethroid(GO:0046684) |
3.9 | 15.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
3.8 | 23.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
3.8 | 60.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
3.7 | 7.4 | GO:1900453 | negative regulation of long term synaptic depression(GO:1900453) |
3.7 | 11.0 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
3.6 | 10.9 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
3.5 | 3.5 | GO:0072098 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
3.5 | 10.5 | GO:0060082 | eye blink reflex(GO:0060082) |
3.5 | 10.5 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
3.5 | 17.3 | GO:0061743 | motor learning(GO:0061743) |
3.5 | 10.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
3.4 | 6.8 | GO:0021836 | chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
3.3 | 23.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
3.2 | 6.5 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
3.2 | 9.7 | GO:0071387 | cellular response to cortisol stimulus(GO:0071387) |
3.2 | 9.6 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
3.2 | 6.3 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
3.2 | 9.5 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
3.2 | 15.8 | GO:0031133 | regulation of axon diameter(GO:0031133) |
3.1 | 12.6 | GO:0042891 | antibiotic transport(GO:0042891) dipeptide transport(GO:0042938) |
3.1 | 18.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
3.1 | 6.2 | GO:0002859 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
3.1 | 9.3 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
3.1 | 9.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
3.0 | 39.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
3.0 | 9.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
3.0 | 9.1 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
3.0 | 18.0 | GO:0060023 | soft palate development(GO:0060023) |
2.9 | 8.7 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
2.9 | 8.7 | GO:0043474 | eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) rhodopsin metabolic process(GO:0046154) |
2.9 | 5.8 | GO:0098923 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
2.9 | 8.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
2.8 | 8.5 | GO:0071163 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
2.8 | 8.4 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
2.8 | 22.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
2.7 | 2.7 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.7 | 16.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
2.7 | 13.4 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
2.7 | 31.9 | GO:0046548 | retinal rod cell development(GO:0046548) |
2.7 | 26.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.6 | 7.9 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
2.6 | 5.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.6 | 10.5 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
2.6 | 2.6 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
2.6 | 12.9 | GO:0060005 | vestibular reflex(GO:0060005) |
2.6 | 7.8 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
2.6 | 7.7 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
2.6 | 7.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
2.5 | 20.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.5 | 9.8 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
2.4 | 9.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.4 | 7.3 | GO:0001966 | thigmotaxis(GO:0001966) |
2.4 | 7.2 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
2.4 | 9.6 | GO:0048691 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
2.4 | 9.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
2.4 | 7.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
2.4 | 9.4 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
2.3 | 21.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
2.3 | 7.0 | GO:0072237 | metanephric proximal tubule development(GO:0072237) |
2.3 | 2.3 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
2.3 | 4.6 | GO:0051867 | general adaptation syndrome, behavioral process(GO:0051867) |
2.3 | 2.3 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
2.3 | 15.9 | GO:0006868 | glutamine transport(GO:0006868) |
2.3 | 29.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
2.2 | 31.1 | GO:0036065 | fucosylation(GO:0036065) |
2.2 | 4.4 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
2.2 | 6.7 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
2.2 | 6.6 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
2.2 | 15.3 | GO:0007144 | female meiosis I(GO:0007144) |
2.2 | 6.5 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
2.1 | 8.5 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
2.1 | 12.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
2.1 | 4.2 | GO:0033058 | directional locomotion(GO:0033058) |
2.1 | 8.4 | GO:0099639 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
2.1 | 4.2 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
2.0 | 6.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
2.0 | 6.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
2.0 | 18.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
2.0 | 12.1 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
2.0 | 4.0 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
2.0 | 7.9 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
2.0 | 11.9 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
2.0 | 7.9 | GO:1900736 | negative regulation of phospholipase C activity(GO:1900275) regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
2.0 | 11.8 | GO:0097350 | neutrophil clearance(GO:0097350) |
2.0 | 5.9 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
2.0 | 9.8 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.9 | 7.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.9 | 5.8 | GO:0002432 | granuloma formation(GO:0002432) |
1.9 | 5.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.9 | 3.8 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
1.9 | 7.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.9 | 7.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.9 | 13.0 | GO:0070269 | pyroptosis(GO:0070269) |
1.8 | 12.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.8 | 3.7 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.8 | 7.3 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
1.8 | 5.5 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.8 | 3.6 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
1.8 | 7.2 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.8 | 9.0 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
1.8 | 9.0 | GO:0030070 | insulin processing(GO:0030070) |
1.8 | 5.4 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.8 | 5.4 | GO:0061205 | paramesonephric duct development(GO:0061205) |
1.8 | 5.3 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
1.8 | 7.1 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
1.8 | 5.3 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
1.8 | 7.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
1.8 | 5.3 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
1.8 | 12.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.8 | 1.8 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
1.8 | 1.8 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
1.7 | 5.2 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
1.7 | 8.7 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
1.7 | 17.4 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.7 | 6.9 | GO:0070671 | response to interleukin-12(GO:0070671) |
1.7 | 5.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
1.7 | 6.9 | GO:0044691 | tooth eruption(GO:0044691) |
1.7 | 17.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.7 | 6.9 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
1.7 | 5.2 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
1.7 | 3.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.7 | 8.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.7 | 6.7 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.7 | 1.7 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.7 | 13.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.7 | 13.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.7 | 15.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
1.7 | 31.6 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
1.7 | 5.0 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
1.6 | 4.9 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
1.6 | 13.1 | GO:0046958 | nonassociative learning(GO:0046958) |
1.6 | 4.9 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.6 | 16.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.6 | 4.9 | GO:0046099 | guanine salvage(GO:0006178) GMP catabolic process(GO:0046038) guanine biosynthetic process(GO:0046099) |
1.6 | 4.9 | GO:1904054 | regulation of cholangiocyte proliferation(GO:1904054) positive regulation of cholangiocyte proliferation(GO:1904056) |
1.6 | 9.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.6 | 102.3 | GO:0008542 | visual learning(GO:0008542) |
1.6 | 4.8 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
1.6 | 4.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.6 | 6.4 | GO:0060437 | lung growth(GO:0060437) |
1.6 | 4.8 | GO:0032218 | riboflavin transport(GO:0032218) |
1.6 | 3.2 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
1.6 | 14.2 | GO:0070543 | response to linoleic acid(GO:0070543) |
1.6 | 18.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
1.6 | 7.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
1.6 | 4.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.6 | 6.2 | GO:0035582 | growth plate cartilage chondrocyte proliferation(GO:0003419) sequestering of BMP in extracellular matrix(GO:0035582) |
1.6 | 23.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
1.5 | 6.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
1.5 | 13.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.5 | 6.2 | GO:0007296 | vitellogenesis(GO:0007296) |
1.5 | 29.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
1.5 | 4.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.5 | 4.6 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
1.5 | 1.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.5 | 57.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.5 | 31.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
1.5 | 7.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
1.5 | 9.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.5 | 1.5 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
1.5 | 5.9 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.5 | 17.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.5 | 5.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
1.4 | 7.2 | GO:0072603 | interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) |
1.4 | 11.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.4 | 5.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.4 | 1.4 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
1.4 | 2.9 | GO:0060022 | hard palate development(GO:0060022) |
1.4 | 8.6 | GO:0015074 | DNA integration(GO:0015074) |
1.4 | 10.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.4 | 9.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
1.4 | 8.5 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
1.4 | 7.0 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
1.4 | 11.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.4 | 8.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.4 | 5.4 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
1.4 | 4.1 | GO:0002584 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
1.4 | 12.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.3 | 4.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.3 | 5.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
1.3 | 6.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.3 | 8.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
1.3 | 2.6 | GO:0071503 | response to heparin(GO:0071503) |
1.3 | 6.6 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
1.3 | 3.9 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
1.3 | 3.9 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.3 | 2.6 | GO:0034059 | response to anoxia(GO:0034059) |
1.3 | 16.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.3 | 6.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
1.3 | 23.0 | GO:0007616 | long-term memory(GO:0007616) |
1.3 | 3.8 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
1.3 | 8.9 | GO:0009405 | pathogenesis(GO:0009405) |
1.3 | 2.5 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) |
1.3 | 6.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.3 | 1.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
1.3 | 2.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.3 | 2.5 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
1.2 | 6.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) |
1.2 | 23.7 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
1.2 | 5.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
1.2 | 6.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.2 | 4.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.2 | 12.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.2 | 3.7 | GO:0055099 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) response to high density lipoprotein particle(GO:0055099) |
1.2 | 8.5 | GO:0099612 | protein localization to axon(GO:0099612) |
1.2 | 13.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.2 | 9.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.2 | 3.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
1.2 | 3.6 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.2 | 4.8 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
1.2 | 4.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.2 | 3.5 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
1.2 | 3.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.2 | 2.3 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
1.2 | 4.7 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
1.2 | 1.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.2 | 16.3 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
1.2 | 10.4 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) |
1.1 | 5.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.1 | 10.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.1 | 2.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.1 | 2.3 | GO:0015811 | L-cystine transport(GO:0015811) |
1.1 | 3.4 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.1 | 5.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.1 | 4.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.1 | 5.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.1 | 12.3 | GO:0006968 | cellular defense response(GO:0006968) |
1.1 | 14.5 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
1.1 | 26.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.1 | 3.3 | GO:0032252 | secretory granule localization(GO:0032252) |
1.1 | 7.7 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
1.1 | 6.6 | GO:0072103 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
1.1 | 10.9 | GO:0019695 | choline metabolic process(GO:0019695) |
1.1 | 4.3 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
1.1 | 1.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
1.1 | 7.5 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.1 | 4.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.1 | 11.8 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.1 | 11.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
1.1 | 3.2 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
1.1 | 7.4 | GO:0051255 | spindle midzone assembly(GO:0051255) |
1.1 | 3.2 | GO:0071691 | cardiac muscle thin filament assembly(GO:0071691) |
1.1 | 4.2 | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
1.1 | 3.2 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
1.0 | 4.2 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) |
1.0 | 6.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.0 | 3.1 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
1.0 | 8.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.0 | 3.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.0 | 8.2 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
1.0 | 6.2 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
1.0 | 4.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.0 | 14.3 | GO:0015816 | glycine transport(GO:0015816) |
1.0 | 3.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.0 | 4.0 | GO:0001554 | luteolysis(GO:0001554) |
1.0 | 12.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.0 | 4.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.0 | 9.0 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
1.0 | 9.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.0 | 5.0 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
1.0 | 5.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.0 | 3.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.0 | 4.0 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
1.0 | 3.9 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.0 | 4.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
1.0 | 3.9 | GO:0050713 | interleukin-18 production(GO:0032621) negative regulation of interleukin-1 beta secretion(GO:0050713) positive regulation of T-helper 17 type immune response(GO:2000318) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
1.0 | 5.8 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
1.0 | 2.9 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
1.0 | 2.9 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.0 | 10.6 | GO:0032060 | bleb assembly(GO:0032060) |
1.0 | 7.7 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.0 | 7.7 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.0 | 11.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.0 | 5.7 | GO:0090367 | negative regulation of mRNA modification(GO:0090367) |
1.0 | 4.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.9 | 4.7 | GO:0050828 | regulation of liquid surface tension(GO:0050828) |
0.9 | 3.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.9 | 2.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.9 | 5.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.9 | 13.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.9 | 1.9 | GO:0045751 | regulation of Toll signaling pathway(GO:0008592) negative regulation of Toll signaling pathway(GO:0045751) positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
0.9 | 0.9 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.9 | 0.9 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.9 | 2.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) formin-nucleated actin cable assembly(GO:0070649) |
0.9 | 5.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.9 | 0.9 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.9 | 9.0 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.9 | 2.7 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.9 | 24.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.9 | 2.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.9 | 5.3 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.9 | 4.4 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.9 | 6.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.9 | 5.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.9 | 0.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.9 | 6.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.9 | 6.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.9 | 2.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.9 | 0.9 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.9 | 3.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.9 | 7.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.8 | 12.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.8 | 4.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.8 | 6.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.8 | 1.7 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.8 | 5.8 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.8 | 1.6 | GO:0010159 | specification of organ position(GO:0010159) |
0.8 | 18.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.8 | 10.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.8 | 3.2 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.8 | 3.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.8 | 6.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.8 | 5.6 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.8 | 2.4 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.8 | 0.8 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.8 | 0.8 | GO:2000437 | regulation of monocyte extravasation(GO:2000437) |
0.8 | 3.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.8 | 3.9 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.8 | 7.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.8 | 5.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.8 | 2.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.8 | 4.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.8 | 2.3 | GO:0071049 | nuclear mRNA surveillance of mRNA 3'-end processing(GO:0071031) nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription(GO:0071049) |
0.8 | 6.8 | GO:0060013 | righting reflex(GO:0060013) |
0.7 | 4.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.7 | 6.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.7 | 1.5 | GO:1905077 | regulation of interleukin-17 secretion(GO:1905076) negative regulation of interleukin-17 secretion(GO:1905077) |
0.7 | 1.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.7 | 2.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.7 | 3.7 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.7 | 3.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.7 | 5.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.7 | 5.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.7 | 2.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.7 | 5.0 | GO:0007614 | short-term memory(GO:0007614) |
0.7 | 4.3 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.7 | 7.9 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.7 | 12.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.7 | 2.9 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.7 | 0.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.7 | 39.2 | GO:0051298 | centrosome duplication(GO:0051298) |
0.7 | 1.4 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.7 | 4.2 | GO:0002118 | aggressive behavior(GO:0002118) |
0.7 | 3.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 18.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.7 | 5.6 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.7 | 1.4 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.7 | 9.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.7 | 4.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.7 | 2.7 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
0.7 | 2.7 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.7 | 2.7 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.7 | 3.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.7 | 2.0 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.7 | 6.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.7 | 2.0 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.7 | 3.3 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.6 | 1.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.6 | 2.6 | GO:0060051 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of protein glycosylation(GO:0060051) |
0.6 | 12.3 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.6 | 14.8 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.6 | 3.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.6 | 1.9 | GO:0016598 | protein arginylation(GO:0016598) |
0.6 | 1.9 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.6 | 10.8 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.6 | 7.0 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.6 | 3.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.6 | 3.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.6 | 10.6 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.6 | 1.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 8.0 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.6 | 16.6 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.6 | 1.2 | GO:0072050 | comma-shaped body morphogenesis(GO:0072049) S-shaped body morphogenesis(GO:0072050) |
0.6 | 4.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.6 | 11.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.6 | 3.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.6 | 3.7 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.6 | 5.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.6 | 0.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.6 | 2.4 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.6 | 2.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.6 | 3.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.6 | 3.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.6 | 1.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.6 | 1.8 | GO:0048749 | compound eye development(GO:0048749) |
0.6 | 2.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.6 | 2.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.6 | 2.9 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.6 | 4.6 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.6 | 5.7 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.6 | 13.7 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.6 | 3.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.6 | 2.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.6 | 1.1 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.6 | 1.1 | GO:1902809 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.6 | 10.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.6 | 21.7 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.5 | 4.9 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.5 | 1.6 | GO:0044026 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.5 | 1.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 8.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.5 | 4.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.5 | 10.1 | GO:1904030 | negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.5 | 2.6 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.5 | 3.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.5 | 1.0 | GO:1903539 | protein localization to postsynaptic membrane(GO:1903539) |
0.5 | 4.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.5 | 0.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.5 | 2.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.5 | 4.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.5 | 9.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.5 | 1.0 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.5 | 6.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.5 | 4.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.5 | 3.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.5 | 7.0 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.5 | 2.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 3.5 | GO:0002858 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.5 | 6.9 | GO:0001675 | acrosome assembly(GO:0001675) |
0.5 | 2.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.5 | 1.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.5 | 2.0 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.5 | 7.3 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.5 | 2.4 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.5 | 7.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.5 | 2.4 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.5 | 2.8 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.5 | 1.9 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.5 | 1.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.5 | 0.9 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.5 | 0.9 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.5 | 1.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.5 | 2.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.5 | 1.4 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.5 | 1.4 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.5 | 0.9 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 2.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.5 | 3.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 6.8 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.5 | 1.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.4 | 5.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.4 | 27.5 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.4 | 1.3 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.4 | 8.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.4 | 6.9 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.4 | 5.2 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.4 | 0.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.4 | 2.6 | GO:1904587 | response to glycoprotein(GO:1904587) |
0.4 | 2.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 3.0 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.4 | 3.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.4 | 1.7 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.4 | 1.7 | GO:0048664 | neuron fate determination(GO:0048664) |
0.4 | 1.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.4 | 3.4 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.4 | 6.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.4 | 2.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 2.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.4 | 2.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.4 | 0.8 | GO:0030578 | PML body organization(GO:0030578) |
0.4 | 22.4 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.4 | 6.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 1.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.4 | 4.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.4 | 1.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.4 | 13.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.4 | 13.0 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.4 | 5.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.4 | 1.2 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.4 | 1.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.4 | 2.3 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.4 | 3.1 | GO:1904116 | response to vasopressin(GO:1904116) |
0.4 | 2.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 6.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.4 | 1.1 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.4 | 1.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 3.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.4 | 4.5 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.4 | 1.9 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.4 | 22.3 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.4 | 0.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 2.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.4 | 2.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.4 | 9.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.4 | 6.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.4 | 3.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.4 | 0.7 | GO:1902211 | regulation of prolactin signaling pathway(GO:1902211) |
0.4 | 0.7 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.4 | 5.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.4 | 0.7 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.4 | 1.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 0.7 | GO:0030575 | nuclear body organization(GO:0030575) Cajal body organization(GO:0030576) |
0.3 | 2.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 15.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.3 | 1.7 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.3 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 3.0 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.3 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 4.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.3 | 1.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 1.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 6.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 5.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.3 | 7.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.3 | 1.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 2.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.3 | 1.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.3 | 1.6 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 1.9 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) endocardial cell differentiation(GO:0060956) |
0.3 | 14.5 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.3 | 2.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 4.9 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.3 | 3.1 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.3 | 2.5 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.3 | 7.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 1.8 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.3 | 2.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 3.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 3.0 | GO:0001975 | response to amphetamine(GO:0001975) |
0.3 | 2.7 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.3 | 6.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.3 | 12.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 5.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.3 | 2.9 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 2.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 34.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 10.4 | GO:0070527 | platelet aggregation(GO:0070527) |
0.3 | 3.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 3.4 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 0.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 2.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.3 | 2.2 | GO:1903429 | regulation of cell maturation(GO:1903429) |
0.3 | 3.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 5.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 1.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 3.8 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
0.3 | 6.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 6.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.3 | 11.7 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.3 | 7.0 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
0.3 | 11.5 | GO:0007051 | spindle organization(GO:0007051) |
0.3 | 3.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 16.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 0.5 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.3 | 0.8 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) sulfate transmembrane transport(GO:1902358) |
0.3 | 9.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 3.7 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.3 | 1.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 9.9 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.3 | 4.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.3 | 3.9 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.3 | 1.3 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 8.3 | GO:0007612 | learning(GO:0007612) |
0.3 | 0.8 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 3.8 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 2.0 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 0.5 | GO:0032273 | positive regulation of protein polymerization(GO:0032273) |
0.2 | 3.9 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 0.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 7.4 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.2 | 0.9 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.2 | 1.6 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.2 | 1.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 2.1 | GO:0048278 | vesicle docking(GO:0048278) |
0.2 | 7.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.2 | 3.4 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 1.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 7.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 7.4 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 6.8 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 1.9 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.2 | 0.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 6.6 | GO:0042073 | intraciliary transport(GO:0042073) |
0.2 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.6 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.2 | 1.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 1.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 1.4 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.2 | 5.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 1.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 4.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.2 | 1.5 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 0.9 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 1.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 1.7 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.2 | 3.0 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.2 | 24.4 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.2 | 1.4 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 0.4 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.2 | 2.5 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 1.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 1.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 0.3 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 2.8 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.2 | 5.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.5 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 2.6 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.2 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 2.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.2 | 1.3 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.2 | 0.2 | GO:0021586 | pons maturation(GO:0021586) |
0.2 | 1.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 3.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 5.3 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.1 | 1.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 1.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 1.9 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 1.0 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.1 | 6.3 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.1 | 2.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 2.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.6 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 45.3 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 1.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 1.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 3.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.5 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 4.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.5 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.1 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.8 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 1.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 2.2 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 2.3 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.1 | 0.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 2.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 2.0 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 3.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 1.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.3 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 5.5 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.1 | 0.2 | GO:0002397 | MHC class I protein complex assembly(GO:0002397) |
0.1 | 0.4 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.4 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.2 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.1 | 0.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 1.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 12.5 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 8.7 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 2.5 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.1 | 0.5 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.5 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 2.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 1.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 1.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 1.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.7 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.1 | 0.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.5 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.1 | 1.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.5 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 2.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 1.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.1 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.3 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.1 | GO:0001662 | behavioral fear response(GO:0001662) fear response(GO:0042596) |
0.0 | 0.0 | GO:1900825 | regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.0 | 1.0 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.0 | 0.2 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.0 | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902041) |
0.0 | 0.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.2 | 66.5 | GO:0032173 | septin collar(GO:0032173) |
16.1 | 48.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
11.9 | 71.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
9.5 | 28.5 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
7.5 | 15.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
7.2 | 86.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
6.5 | 38.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
5.8 | 17.5 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
5.3 | 15.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
5.0 | 15.0 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
4.5 | 4.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
4.3 | 26.0 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
4.3 | 25.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
4.3 | 12.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
3.8 | 7.7 | GO:0044307 | dendritic branch(GO:0044307) |
3.6 | 17.9 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
3.5 | 24.8 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
3.5 | 28.2 | GO:0032584 | growth cone membrane(GO:0032584) |
3.4 | 10.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
2.9 | 11.8 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
2.9 | 8.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
2.8 | 8.5 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
2.8 | 8.5 | GO:0005592 | collagen type XI trimer(GO:0005592) |
2.8 | 11.2 | GO:0044308 | axonal spine(GO:0044308) |
2.8 | 27.7 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.8 | 38.8 | GO:0031045 | dense core granule(GO:0031045) |
2.8 | 22.0 | GO:0016589 | NURF complex(GO:0016589) |
2.6 | 7.9 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
2.5 | 7.5 | GO:0033557 | Slx1-Slx4 complex(GO:0033557) |
2.5 | 12.3 | GO:0035976 | AP1 complex(GO:0035976) |
2.5 | 14.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
2.3 | 39.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
2.2 | 6.7 | GO:0060187 | cell pole(GO:0060187) |
2.1 | 8.5 | GO:1990769 | proximal neuron projection(GO:1990769) |
2.0 | 4.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
2.0 | 10.1 | GO:0098845 | postsynaptic endosome(GO:0098845) |
2.0 | 8.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
2.0 | 5.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.8 | 9.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.8 | 5.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.8 | 10.9 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.8 | 16.1 | GO:0032009 | early phagosome(GO:0032009) |
1.7 | 20.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.7 | 5.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.7 | 10.1 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
1.6 | 30.3 | GO:0097449 | astrocyte projection(GO:0097449) |
1.6 | 4.8 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
1.6 | 3.2 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
1.5 | 4.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.5 | 12.4 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
1.5 | 11.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.5 | 44.0 | GO:0030673 | axolemma(GO:0030673) |
1.4 | 5.8 | GO:1990005 | granular vesicle(GO:1990005) |
1.4 | 12.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.4 | 4.3 | GO:0043511 | inhibin complex(GO:0043511) |
1.4 | 15.6 | GO:0033270 | paranode region of axon(GO:0033270) |
1.4 | 2.7 | GO:0036398 | TCR signalosome(GO:0036398) |
1.4 | 9.6 | GO:0044327 | dendritic spine head(GO:0044327) |
1.4 | 14.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.4 | 107.1 | GO:0043198 | dendritic shaft(GO:0043198) |
1.3 | 17.5 | GO:0071437 | invadopodium(GO:0071437) |
1.3 | 6.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
1.3 | 2.7 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.3 | 7.6 | GO:0033269 | internode region of axon(GO:0033269) |
1.3 | 5.1 | GO:0032280 | symmetric synapse(GO:0032280) |
1.3 | 10.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.3 | 3.8 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
1.3 | 45.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.2 | 8.7 | GO:0031105 | septin complex(GO:0031105) |
1.2 | 30.9 | GO:0044295 | axonal growth cone(GO:0044295) |
1.2 | 8.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.2 | 23.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.2 | 3.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.2 | 19.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.1 | 5.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.1 | 7.7 | GO:0032437 | cuticular plate(GO:0032437) |
1.1 | 5.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
1.1 | 5.4 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
1.1 | 12.9 | GO:0005796 | Golgi lumen(GO:0005796) |
1.1 | 25.3 | GO:0043194 | axon initial segment(GO:0043194) |
1.0 | 3.1 | GO:0098833 | presynaptic endosome(GO:0098830) presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
1.0 | 4.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.0 | 1.0 | GO:0044301 | climbing fiber(GO:0044301) |
1.0 | 22.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.0 | 4.1 | GO:0097427 | microtubule bundle(GO:0097427) |
1.0 | 6.1 | GO:0097255 | R2TP complex(GO:0097255) |
1.0 | 6.8 | GO:0090543 | Flemming body(GO:0090543) |
1.0 | 4.8 | GO:0043203 | axon hillock(GO:0043203) |
0.9 | 21.8 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.9 | 3.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.9 | 1.9 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.9 | 10.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.9 | 4.6 | GO:0089701 | U2AF(GO:0089701) |
0.9 | 20.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.9 | 6.2 | GO:0001652 | granular component(GO:0001652) |
0.9 | 7.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.9 | 9.7 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.9 | 17.2 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.9 | 2.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.9 | 3.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.8 | 5.8 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.8 | 5.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.8 | 1.6 | GO:1990923 | PET complex(GO:1990923) |
0.8 | 4.8 | GO:0071547 | piP-body(GO:0071547) |
0.8 | 3.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.8 | 12.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.8 | 12.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.8 | 3.8 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.8 | 43.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.8 | 10.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.7 | 32.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.7 | 5.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 2.2 | GO:0044609 | DBIRD complex(GO:0044609) |
0.7 | 13.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.7 | 15.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.7 | 1.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.7 | 5.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.7 | 2.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.7 | 2.1 | GO:0055087 | Ski complex(GO:0055087) |
0.7 | 8.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.7 | 3.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.7 | 96.6 | GO:0030426 | growth cone(GO:0030426) |
0.7 | 15.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.7 | 16.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.7 | 4.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.7 | 5.9 | GO:1990635 | proximal dendrite(GO:1990635) |
0.7 | 2.0 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.6 | 42.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.6 | 3.2 | GO:0097060 | synaptic membrane(GO:0097060) |
0.6 | 5.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.6 | 1.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.6 | 3.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.6 | 1.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.6 | 1.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.6 | 1.9 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.6 | 6.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 84.3 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 66.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.6 | 22.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.6 | 3.6 | GO:0036396 | MIS complex(GO:0036396) |
0.6 | 11.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.6 | 4.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.6 | 2.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 9.7 | GO:0010369 | chromocenter(GO:0010369) |
0.6 | 2.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.6 | 3.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 8.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.6 | 2.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.6 | 1.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.5 | 2.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.5 | 30.1 | GO:0043195 | terminal bouton(GO:0043195) |
0.5 | 6.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.5 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
0.5 | 2.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.5 | 6.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.5 | 14.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.5 | 1.4 | GO:0033503 | HULC complex(GO:0033503) |
0.5 | 8.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.5 | 4.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 12.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 4.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.5 | 0.9 | GO:0016342 | catenin complex(GO:0016342) |
0.5 | 6.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 2.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 24.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 3.9 | GO:0034399 | nuclear periphery(GO:0034399) |
0.4 | 67.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.4 | 4.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 52.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.4 | 1.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.4 | 0.8 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.4 | 5.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.4 | 2.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 1.6 | GO:1990745 | GARP complex(GO:0000938) EARP complex(GO:1990745) |
0.4 | 2.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.4 | 59.9 | GO:0060076 | excitatory synapse(GO:0060076) |
0.4 | 12.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 3.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.4 | 3.0 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 3.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 8.9 | GO:0043679 | axon terminus(GO:0043679) |
0.4 | 3.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.4 | 7.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.4 | 4.0 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.4 | 15.4 | GO:0072686 | mitotic spindle(GO:0072686) |
0.4 | 2.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.4 | 3.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 8.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 6.1 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.3 | 5.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 8.1 | GO:0002102 | podosome(GO:0002102) |
0.3 | 3.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 2.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 4.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 2.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 60.8 | GO:0031252 | cell leading edge(GO:0031252) |
0.3 | 1.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 3.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 9.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 4.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 14.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 27.1 | GO:0005814 | centriole(GO:0005814) |
0.3 | 3.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.3 | 6.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 1.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 3.3 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 2.3 | GO:0044754 | autolysosome(GO:0044754) |
0.3 | 1.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 4.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 1.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 2.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 1.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 1.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 17.9 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.2 | 13.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.7 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.2 | 7.0 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.2 | 2.1 | GO:0070187 | telosome(GO:0070187) |
0.2 | 6.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 1.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.9 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.9 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.2 | 1.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 2.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 12.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.8 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.2 | 4.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 1.0 | GO:0097361 | CIA complex(GO:0097361) |
0.2 | 3.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 1.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 2.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 6.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 1.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 2.5 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 4.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 0.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 21.2 | GO:0005819 | spindle(GO:0005819) |
0.2 | 0.9 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 3.8 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 10.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 2.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 11.2 | GO:0098794 | postsynapse(GO:0098794) |
0.2 | 3.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 2.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 2.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 2.3 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 3.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 8.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 41.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 1.4 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.8 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 2.5 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 10.3 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 3.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 3.0 | GO:0005903 | brush border(GO:0005903) |
0.1 | 20.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 4.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 3.8 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 1.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 24.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 8.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 1.6 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 7.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 11.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 24.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 3.1 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.1 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.4 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 51.0 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.9 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.1 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 7.5 | GO:0045202 | synapse(GO:0045202) |
0.1 | 5.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 1.3 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 5.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 1.4 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 1.1 | GO:0098791 | Golgi subcompartment(GO:0098791) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.8 | 47.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
10.2 | 61.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
7.6 | 52.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
5.7 | 34.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
5.5 | 32.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
5.3 | 36.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
5.0 | 15.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
4.8 | 19.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
4.7 | 23.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
4.3 | 129.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
4.3 | 25.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
4.2 | 12.6 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
4.2 | 33.2 | GO:0030274 | LIM domain binding(GO:0030274) |
4.1 | 12.3 | GO:0005119 | smoothened binding(GO:0005119) |
4.1 | 12.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
4.0 | 15.9 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
3.7 | 26.0 | GO:0048495 | Roundabout binding(GO:0048495) |
3.7 | 26.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
3.7 | 22.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
3.7 | 11.1 | GO:0005135 | erythropoietin receptor binding(GO:0005128) interleukin-3 receptor binding(GO:0005135) |
3.3 | 33.3 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
3.3 | 16.6 | GO:0042731 | PH domain binding(GO:0042731) |
3.3 | 13.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
3.3 | 39.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
3.2 | 12.8 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
3.2 | 12.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
3.1 | 43.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
3.1 | 6.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
3.0 | 38.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
3.0 | 8.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
2.8 | 8.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
2.8 | 8.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
2.7 | 13.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
2.7 | 32.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.6 | 7.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
2.6 | 10.5 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
2.6 | 10.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
2.6 | 15.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.5 | 17.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.5 | 24.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
2.4 | 7.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
2.3 | 28.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
2.3 | 23.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
2.3 | 9.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
2.3 | 13.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
2.2 | 6.7 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
2.2 | 24.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
2.2 | 6.6 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
2.2 | 8.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
2.2 | 8.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
2.2 | 8.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.1 | 12.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
2.1 | 6.4 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
2.1 | 10.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
2.1 | 42.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
2.1 | 10.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
2.1 | 6.2 | GO:0016015 | morphogen activity(GO:0016015) |
2.0 | 12.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
2.0 | 13.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
2.0 | 2.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
2.0 | 4.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
2.0 | 7.9 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
1.9 | 7.8 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.9 | 5.8 | GO:0015489 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
1.9 | 5.7 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
1.8 | 5.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.8 | 5.5 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
1.8 | 12.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.8 | 5.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.8 | 5.3 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
1.8 | 3.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.8 | 14.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.7 | 13.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.7 | 5.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
1.7 | 6.7 | GO:0034584 | piRNA binding(GO:0034584) |
1.7 | 11.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.7 | 5.0 | GO:0070976 | TIR domain binding(GO:0070976) |
1.6 | 4.9 | GO:0098919 | structural constituent of postsynaptic specialization(GO:0098879) structural constituent of postsynaptic density(GO:0098919) |
1.6 | 13.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.6 | 4.8 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.6 | 19.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.6 | 9.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
1.6 | 4.8 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
1.6 | 7.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.6 | 14.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
1.6 | 3.2 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
1.6 | 4.7 | GO:0031826 | follicle-stimulating hormone receptor binding(GO:0031762) type 2A serotonin receptor binding(GO:0031826) |
1.5 | 6.0 | GO:0099510 | calcium ion binding involved in regulation of cytosolic calcium ion concentration(GO:0099510) |
1.5 | 10.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.5 | 4.4 | GO:0035939 | microsatellite binding(GO:0035939) |
1.5 | 7.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.4 | 10.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.4 | 15.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.4 | 4.2 | GO:0008481 | sphinganine kinase activity(GO:0008481) |
1.4 | 5.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.4 | 4.2 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
1.4 | 7.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.4 | 4.2 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
1.4 | 5.6 | GO:0050659 | chondroitin sulfotransferase activity(GO:0034481) chondroitin 4-sulfotransferase activity(GO:0047756) N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
1.3 | 14.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.3 | 38.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.3 | 3.9 | GO:0004096 | catalase activity(GO:0004096) |
1.3 | 1.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.3 | 101.9 | GO:0005518 | collagen binding(GO:0005518) |
1.3 | 3.9 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
1.3 | 16.6 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
1.2 | 6.2 | GO:0015142 | tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.2 | 5.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.2 | 14.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
1.2 | 12.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
1.2 | 11.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
1.2 | 3.7 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
1.2 | 4.9 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
1.2 | 10.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.2 | 3.6 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
1.2 | 3.6 | GO:0000827 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) |
1.2 | 7.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
1.2 | 4.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.2 | 7.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.2 | 5.9 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.2 | 7.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.2 | 3.5 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
1.2 | 28.8 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.1 | 16.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.1 | 5.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
1.1 | 10.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.1 | 3.4 | GO:0016403 | dimethylargininase activity(GO:0016403) |
1.1 | 6.8 | GO:0035197 | siRNA binding(GO:0035197) |
1.1 | 3.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
1.1 | 4.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.1 | 14.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.1 | 6.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.1 | 6.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.1 | 4.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.1 | 23.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.1 | 6.4 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
1.1 | 8.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.1 | 6.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.1 | 52.8 | GO:0048365 | Rac GTPase binding(GO:0048365) |
1.0 | 5.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.0 | 6.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.0 | 3.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
1.0 | 14.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.0 | 42.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
1.0 | 2.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.0 | 4.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.0 | 3.0 | GO:0030626 | U12 snRNA binding(GO:0030626) |
1.0 | 5.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.0 | 14.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.0 | 13.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.0 | 7.7 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.9 | 8.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.9 | 9.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.9 | 17.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.9 | 3.7 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.9 | 5.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.9 | 5.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.9 | 6.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.9 | 6.0 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.9 | 4.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.8 | 5.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.8 | 7.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.8 | 4.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.8 | 1.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.8 | 22.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.8 | 5.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.8 | 2.5 | GO:0019807 | aspartoacylase activity(GO:0019807) |
0.8 | 8.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.8 | 13.8 | GO:0031005 | filamin binding(GO:0031005) |
0.8 | 3.2 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.8 | 8.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.8 | 3.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.8 | 20.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.8 | 3.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.8 | 9.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.8 | 7.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.8 | 10.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.8 | 8.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.8 | 13.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.8 | 4.6 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.8 | 10.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.8 | 3.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.7 | 12.7 | GO:0005522 | profilin binding(GO:0005522) |
0.7 | 18.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.7 | 3.7 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.7 | 8.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.7 | 3.7 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.7 | 2.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.7 | 10.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.7 | 24.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.7 | 8.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.7 | 9.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.7 | 3.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.7 | 1.4 | GO:0019961 | interferon binding(GO:0019961) |
0.7 | 16.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.7 | 6.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.7 | 4.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 4.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.7 | 3.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.7 | 2.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.6 | 3.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.6 | 11.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.6 | 77.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.6 | 9.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.6 | 19.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.6 | 1.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.6 | 1.9 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.6 | 3.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.6 | 3.7 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.6 | 13.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.6 | 13.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 3.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.6 | 1.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.6 | 2.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.6 | 7.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.6 | 2.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.6 | 1.7 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
0.6 | 3.4 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.6 | 17.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.6 | 2.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.6 | 9.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.5 | 1.6 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
0.5 | 2.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.5 | 17.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.5 | 3.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.5 | 3.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 2.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.5 | 31.1 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.5 | 2.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.5 | 4.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.5 | 1.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.5 | 4.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 6.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.5 | 1.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 1.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.5 | 1.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.5 | 23.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 5.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 8.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.5 | 8.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 8.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 10.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.5 | 2.9 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.5 | 10.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.5 | 3.9 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.5 | 7.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.5 | 13.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.5 | 3.8 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.5 | 10.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 1.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.5 | 7.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 19.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 26.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.4 | 4.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.4 | 2.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 2.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.4 | 5.9 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 2.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 2.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 4.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 2.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.4 | 1.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 3.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.4 | 0.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.4 | 1.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 1.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.4 | 33.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 2.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.4 | 3.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.4 | 10.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 2.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 2.7 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.4 | 7.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.4 | 10.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.4 | 2.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 6.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 1.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 6.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.4 | 11.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.4 | 2.1 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 1.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.3 | 1.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 4.4 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.3 | 1.7 | GO:0015168 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) |
0.3 | 127.9 | GO:0005525 | GTP binding(GO:0005525) |
0.3 | 7.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 2.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 9.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.3 | 20.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.3 | 13.5 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.3 | 4.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 4.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 2.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.3 | 6.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 3.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 2.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 4.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 3.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 0.9 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 2.1 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.3 | 3.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 2.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 5.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 2.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 2.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 3.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 2.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 1.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 7.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 1.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 3.3 | GO:0035004 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) phosphatidylinositol 3-kinase activity(GO:0035004) |
0.3 | 1.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.3 | 9.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 1.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 1.3 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.3 | 5.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 1.8 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.3 | 2.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 2.0 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 4.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 2.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 4.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 3.4 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 2.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 4.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 2.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 3.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.7 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.2 | 8.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 25.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 1.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 4.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 2.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 48.5 | GO:0015631 | tubulin binding(GO:0015631) |
0.2 | 0.8 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.2 | 4.8 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.2 | 5.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 4.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 11.8 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 1.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 6.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 23.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 2.0 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 3.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 1.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 2.3 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.2 | 0.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 8.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 1.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 2.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 5.2 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 3.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 3.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 2.4 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 1.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.4 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.1 | 1.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 5.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 1.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.4 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 1.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 2.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.4 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.1 | 1.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 5.6 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 2.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 2.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.7 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.1 | 1.4 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 1.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 6.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 8.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.9 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.9 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 1.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 1.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.0 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 2.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 2.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 1.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 1.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 1.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.8 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
2.0 | 20.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
2.0 | 65.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
2.0 | 33.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.6 | 62.7 | PID REELIN PATHWAY | Reelin signaling pathway |
1.5 | 46.3 | PID RAS PATHWAY | Regulation of Ras family activation |
1.5 | 13.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.4 | 17.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.3 | 39.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
1.3 | 10.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
1.2 | 12.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.1 | 6.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.0 | 41.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.0 | 11.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.0 | 20.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.0 | 33.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.0 | 41.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.0 | 13.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.9 | 45.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.9 | 13.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.9 | 48.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.8 | 12.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.8 | 11.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.7 | 5.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.7 | 4.8 | PID EPO PATHWAY | EPO signaling pathway |
0.7 | 13.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.7 | 8.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 5.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.6 | 6.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.6 | 36.9 | PID P73PATHWAY | p73 transcription factor network |
0.6 | 30.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 17.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 12.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.5 | 118.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 6.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 80.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 6.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.5 | 17.3 | PID FGF PATHWAY | FGF signaling pathway |
0.5 | 9.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 16.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.5 | 3.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.5 | 20.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 7.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 3.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 7.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 5.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 5.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 4.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.4 | 3.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 5.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.4 | 7.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 18.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 10.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 8.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 4.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 2.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 2.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 2.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 3.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.3 | 5.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 2.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 11.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 5.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 13.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 3.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 7.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 7.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 6.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 1.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 2.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 2.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 3.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 2.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 2.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 2.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 2.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 4.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 1.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 0.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 2.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 0.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 5.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 3.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 5.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.8 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 58.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
2.8 | 36.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
2.5 | 54.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.4 | 38.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.3 | 41.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.2 | 6.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
2.1 | 8.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
2.1 | 10.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.9 | 54.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.8 | 45.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.7 | 90.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.7 | 31.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.6 | 24.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.6 | 29.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.6 | 24.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.3 | 21.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.3 | 36.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.3 | 21.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.2 | 10.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
1.2 | 25.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.1 | 3.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.1 | 13.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
1.1 | 15.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.0 | 31.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.0 | 60.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.0 | 9.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.0 | 4.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
1.0 | 23.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.0 | 20.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.0 | 19.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.0 | 10.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.0 | 17.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.9 | 11.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.9 | 14.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.9 | 6.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.9 | 9.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.8 | 10.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.8 | 10.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.8 | 10.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.8 | 2.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.8 | 13.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.8 | 7.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.8 | 4.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.8 | 48.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.7 | 9.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.7 | 5.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.7 | 9.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.7 | 29.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.7 | 73.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.7 | 6.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.7 | 5.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.6 | 5.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.6 | 9.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.6 | 30.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.6 | 18.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 1.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.5 | 6.5 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.5 | 42.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.5 | 4.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.5 | 3.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.5 | 3.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.5 | 26.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.5 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 2.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.5 | 12.7 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.5 | 24.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 5.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.4 | 11.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 2.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.4 | 7.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.4 | 4.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 7.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 12.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.4 | 3.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 7.7 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.4 | 11.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 2.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 3.9 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.4 | 2.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.4 | 17.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 8.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 6.9 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.4 | 3.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.4 | 4.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 3.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 2.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 1.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 5.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 7.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 2.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 16.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 7.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 17.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.3 | 44.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.3 | 2.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 22.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 5.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 32.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 2.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 4.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 5.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 2.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.3 | 17.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 4.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 2.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 5.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 14.4 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 1.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 6.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 2.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 12.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 7.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 3.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 2.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 1.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 1.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 1.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 2.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 2.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 6.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 0.6 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 4.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 2.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 1.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.8 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 2.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 3.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.7 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 2.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 7.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 2.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 0.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |